SCHEMBL19974316

SCHEMBL19974316

Cc1ccccc1COS(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.44
CDK4 P11802 2/20 0.41
CCND1 P24385 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
CTBP2 P56545 1/20 0.40
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
ACHE P22303 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL27764015 0.98 MAOB (0.42) MAOBCDK4CCND1MEN1KMT2A
SCHEMBL5273095 0.87 CYP1A2 (0.41) MEN1KMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL29664948 0.86 TAAR1 (0.39) MAOBCDK4CCND1MEN1KMT2A
SCHEMBL776265 0.86 MAOB (0.45) MAOBCDK4CCND1MEN1KMT2A
SCHEMBL1229717 0.85 KEAP1 (0.42) ALDH1A1GAACYP1A2CYP3A4CYP2D6
SCHEMBL4888961 0.82 CYP1A2 (0.39) PTGS1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3589537 0.81 TAAR1 (0.47) MEN1KMT2ATAAR1CTBP2PTGS1
SCHEMBL29284824 0.79 MEN1 (0.42) MAOBCDK4CCND1MEN1KMT2A
SCHEMBL8516047 0.79 CA1 (0.43) CYP1A2CYP3A4
SCHEMBL20462961 0.78 IDO1 (0.52) TAAR1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4667473-A2 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2025-12-24 EP disclosed
EP-3724193-B1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF AGRO BV (NL) 2024-09-11 EP disclosed
CN-118239957-A Process for the preparation of 2-exo- (2-methylbenzyloxy) -1-methyl-4-isopropyl-7-oxabicyclo [2.2.1] heptane 巴斯夫农业公司 2024-06-25 CN disclosed
US-11897895-B2 Process for preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicy-clo[2.2.1]heptane BASF Agro B.V. (NL) 2024-02-13 US disclosed
US-11384093-B2 Process for preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane BASF Agro B.V. (NL) 2022-07-12 US disclosed
US-11384093-B2 Process for preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane BASF Agro B.V. (NL) 2022-07-12 US disclosed
US-20210163496-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2021-06-03 US disclosed
US-20210163496-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2021-06-03 US disclosed
EP-3601295-B1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF AGRO BV (NL) 2021-05-12 EP disclosed
EP-3601295-B1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF AGRO BV (NL) 2021-05-12 EP disclosed
EP-3515918-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2019-07-31 EP disclosed
WO-2019115347-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2019-06-20 WO disclosed
WO-2019115347-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2019-06-20 WO disclosed
CN-109790174-A Be used to prepare 2- it is outer-method of (2- methylbenzyloxy) -1- methyl -4- isopropyl -7- oxabicyclo [2.2.1] heptane 巴斯夫农业公司 2019-05-21 CN disclosed
WO-2018177907-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2018-10-04 WO disclosed
WO-2018149676-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2018-08-23 WO disclosed
WO-2018050518-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2018-03-22 WO disclosed
WO-2018050518-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE BASF Agro B.V. (NL) 2018-03-22 WO disclosed
CN-106478326-A The synthetic method of one class diarylmethanes 北京大学 2017-03-08 CN disclosed
CN-101652354-A insecticidal aryl isoxazoline derivatives BAYER CROPSCIENCE AG DE 2010-02-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163496-A1 PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE EXOC1, EXOC4, EXOC3 MAOB 818/4885CDK4 4413/4885CCND1 4635/4885
US-11897895-B2 Process for preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicy-clo[2.2.1]heptane EXOC1, EXOC4, EXOC3 MAOB 586/4885CDK4 4592/4885CCND1 4571/4885
US-11384093-B2 Process for preparing 2-exo-(2-Methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane EXOC1, CYP8B1, EXOC3 MAOB 1941/4885CDK4 3704/4885CCND1 3159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.